Thermo Fisher Scientific Inc. (NYSE: TMO) announced fourth-quarter 2022 financial results, reporting a double-digit fall in adjusted earnings and an increase in revenues. Fourth-quarter revenues increased 7% annually to $11.5 billion, with strong contributions from the core laboratory products and services segment. Adjusted earnings, meanwhile, declined to $5.40 per share in the most recent quarter […]
“Thermo Fisher Scientific Inc. (NYSE: TMO) announced fourth-quarter 2022 financial results, reporting a double-digit fall in adjusted earnings and an increase in revenues. Fourth-quarter revenues increased 7% annually to $11.5 billion, with strong contributions from the core laboratory products and services segment. Adjusted earnings, meanwhile, declined to $5.40 per share in the most recent quarter […]
· February 1, 2023
Thermo Fisher Scientific Inc. (NYSE: TMO) announced fourth-quarter 2022 financial results, reporting a double-digit fall in adjusted earnings and an increase in revenues.
Fourth-quarter revenues increased 7% annually to $11.5 billion, with strong contributions from the core laboratory products and services segment.
Adjusted earnings, meanwhile, declined to $5.40 per share in the most recent quarter from $6.54 per share a year earlier. The reported profit was $1.58 billion or $4.01 per share, compared to $1.66 billion or $4.17 per share in the prior-year quarter.
